FDA Inspection
LGM Pharma LLCLGM Pharma LLC – FDA Inspection, Dec 4, 2018
Record Details
This FDA Inspection record concerns LGM Pharma LLC, with an inspection on December 4, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6dbfe703-41e1-4652-8fbb-a378bed4c926
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1073414
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of LGM Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2026 | Not classified | Cincinnati District Office | |
| June 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 8, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LGM Pharma LLC
- FDA Inspection 1312800 - 2026-03-12
- FDA Inspection 1242488 - 2024-06-28
- FDA Inspection 1166776 - 2022-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.